NTRA
Price
$328.93
Change
+$2.79 (+0.86%)
Updated
Sep 11 closing price
Capitalization
47.41B
60 days until earnings call
Intraday BUY SELL Signals
RCEL
Price
$9.88
Change
+$0.02 (+0.20%)
Updated
Sep 11 closing price
Capitalization
305.09M
54 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

NTRA vs RCEL

NTRA vs RCEL Comparison Chart in %
View a ticker or compare two or three
VS
NTRA vs. RCEL commentary
Sep 13, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is NTRA is a StrongBuy and RCEL is a Hold.

Interact to see
Advertisement
SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
NTRA($47.4B) has a higher market cap than RCEL($305M). RCEL YTD gains are higher at: 186.377 vs. NTRA (43.581). RCEL has higher annual earnings (EBITDA): -35.15M vs. NTRA (-183.08M). NTRA has more cash in the bank: 1.09B vs. RCEL (11.1M). RCEL has less debt than NTRA: RCEL (48.5M) vs NTRA (238M). NTRA has higher revenues than RCEL: NTRA (2.71B) vs RCEL (75.6M).
NTRARCELNTRA / RCEL
Capitalization47.4B305M15,541%
EBITDA-183.08M-35.15M521%
Gain YTD43.581186.37723%
P/E RatioN/AN/A-
Revenue2.71B75.6M3,581%
Total Cash1.09B11.1M9,838%
Total Debt238M48.5M491%
FUNDAMENTALS RATINGS
NTRA vs RCEL: Fundamental Ratings
NTRA
RCEL
OUTLOOK RATING
1..100
2284
VALUATION
overvalued / fair valued / undervalued
1..100
52
Fair valued
62
Fair valued
PROFIT vs RISK RATING
1..100
17100
SMR RATING
1..100
94100
PRICE GROWTH RATING
1..100
3534
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
8575

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

NTRA's Valuation (52) in the Biotechnology industry is in the same range as RCEL (62) in the null industry. This means that NTRA’s stock grew similarly to RCEL’s over the last 12 months.

NTRA's Profit vs Risk Rating (17) in the Biotechnology industry is significantly better than the same rating for RCEL (100) in the null industry. This means that NTRA’s stock grew significantly faster than RCEL’s over the last 12 months.

NTRA's SMR Rating (94) in the Biotechnology industry is in the same range as RCEL (100) in the null industry. This means that NTRA’s stock grew similarly to RCEL’s over the last 12 months.

RCEL's Price Growth Rating (34) in the null industry is in the same range as NTRA (35) in the Biotechnology industry. This means that RCEL’s stock grew similarly to NTRA’s over the last 12 months.

RCEL's P/E Growth Rating (100) in the null industry is in the same range as NTRA (100) in the Biotechnology industry. This means that RCEL’s stock grew similarly to NTRA’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
NTRARCEL
RSI
ODDS (%)
Bearish Trend 2 days ago
66%
Bearish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
76%
Bullish Trend 2 days ago
80%
Momentum
ODDS (%)
Bearish Trend 2 days ago
85%
Bearish Trend 2 days ago
85%
MACD
ODDS (%)
Bearish Trend 2 days ago
71%
Bearish Trend 2 days ago
84%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
81%
Bearish Trend 2 days ago
82%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
82%
Bullish Trend 2 days ago
83%
Advances
ODDS (%)
Bullish Trend 9 days ago
79%
Bullish Trend 9 days ago
77%
Declines
ODDS (%)
Bearish Trend 12 days ago
77%
Bearish Trend 3 days ago
80%
BollingerBands
ODDS (%)
Bearish Trend 4 days ago
60%
Bearish Trend 2 days ago
90%
Aroon
ODDS (%)
Bullish Trend 2 days ago
81%
Bullish Trend 2 days ago
85%
COMPARISON
Comparison
Sep 13, 2026
Stock price -- (NTRA: $328.93 vs. RCEL: $9.88)
Brand notoriety: NTRA and RCEL are both not notable
NTRA represents the Medical Specialties, while RCEL is part of the Medical/Nursing Services industry
Current volume relative to the 65-day Moving Average: NTRA: 72% vs. RCEL: 49%
Market capitalization -- NTRA: $47.41B vs. RCEL: $305.09M
NTRA [@Medical Specialties] is valued at $47.41B. RCEL’s [@Medical/Nursing Services] market capitalization is $305.09M. The market cap for tickers in the [@Medical Specialties] industry ranges from $27 to $3.82T. The market cap for tickers in the [@Medical/Nursing Services] industry ranges from $1.86K to $176.41B. The average market capitalization across the [@Medical Specialties] industry is $18.5B. The average market capitalization across the [@Medical/Nursing Services] industry is $5.46B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

NTRA’s FA Score shows that 1 FA rating(s) are green while RCEL’s FA Score has 0 green FA rating(s).

  • NTRA’s FA Score: 1 green, 4 red.
  • RCEL’s FA Score: 0 green, 5 red.
According to our system of comparison, NTRA is a better buy in the long-term than RCEL.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

NTRA’s TA Score shows that 2 TA indicator(s) are bullish while RCEL’s TA Score has 3 bullish TA indicator(s).

  • NTRA’s TA Score: 2 bullish, 6 bearish.
  • RCEL’s TA Score: 3 bullish, 5 bearish.
According to our system of comparison, RCEL is a better buy in the short-term than NTRA.

Price Growth

NTRA (@Medical Specialties) experienced а +0.23% price change this week, while RCEL (@Medical/Nursing Services) price change was -11.79% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was -3.54%. For the same industry, the average monthly price growth was +4.08%, and the average quarterly price growth was +36.27%.

The average weekly price growth across all stocks in the @Medical/Nursing Services industry was -5.01%. For the same industry, the average monthly price growth was -8.95%, and the average quarterly price growth was -6.66%.

Reported Earning Dates

NTRA is expected to report earnings on Nov 11, 2026.

RCEL is expected to report earnings on Nov 05, 2026.

Industries' Descriptions

@Medical Specialties (-3.54% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

@Medical/Nursing Services (-5.01% weekly)

The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.

View a ticker or compare two or three
NTRA
Daily Signal:
Gain/Loss:
RCEL
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
STT193.402.10
+1.10%
State Street Corp
DARE0.71N/A
+0.13%
Dare Bioscience Inc.
CSTL32.330.01
+0.03%
Castle Biosciences
SON47.84-0.59
-1.22%
Sonoco Products Company
LOVE13.91-0.35
-2.45%
Lovesac Company (The)

NTRA and

Correlation & Price change

A.I.dvisor indicates that over the last year, NTRA has been loosely correlated with ISRG. These tickers have moved in lockstep 53% of the time. This A.I.-generated data suggests there is some statistical probability that if NTRA jumps, then ISRG could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NTRA
1D Price
Change %
NTRA100%
+0.86%
ISRG - NTRA
53%
Loosely correlated
+2.41%
ADPT - NTRA
52%
Loosely correlated
-0.12%
NEO - NTRA
51%
Loosely correlated
-1.65%
GH - NTRA
50%
Loosely correlated
-1.04%
PSNL - NTRA
48%
Loosely correlated
-0.73%
More

RCEL and

Correlation & Price change

A.I.dvisor indicates that over the last year, RCEL has been loosely correlated with SENS. These tickers have moved in lockstep 36% of the time. This A.I.-generated data suggests there is some statistical probability that if RCEL jumps, then SENS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RCEL
1D Price
Change %
RCEL100%
+0.20%
SENS - RCEL
36%
Loosely correlated
-0.91%
MBOT - RCEL
33%
Poorly correlated
-0.68%
NTRA - RCEL
30%
Poorly correlated
+0.86%
SGHT - RCEL
30%
Poorly correlated
+1.69%
VCYT - RCEL
29%
Poorly correlated
-2.76%
More